These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
494 related items for PubMed ID: 10644360
1. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells. Holtappels R, Thomas D, Podlech J, Geginat G, Steffens HP, Reddehase MJ. J Virol; 2000 Feb; 74(4):1871-84. PubMed ID: 10644360 [Abstract] [Full Text] [Related]
2. Cytomegalovirus encodes a positive regulator of antigen presentation. Holtappels R, Gillert-Marien D, Thomas D, Podlech J, Deegen P, Herter S, Oehrlein-Karpi SA, Strand D, Wagner M, Reddehase MJ. J Virol; 2006 Aug; 80(15):7613-24. PubMed ID: 16840340 [Abstract] [Full Text] [Related]
3. Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. Holtappels R, Grzimek NK, Simon CO, Thomas D, Dreis D, Reddehase MJ. J Virol; 2002 Jun; 76(12):6044-53. PubMed ID: 12021337 [Abstract] [Full Text] [Related]
4. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. Gold MC, Munks MW, Wagner M, Koszinowski UH, Hill AB, Fling SP. J Immunol; 2002 Jul 01; 169(1):359-65. PubMed ID: 12077265 [Abstract] [Full Text] [Related]
5. Positive Role of the MHC Class-I Antigen Presentation Regulator m04/gp34 of Murine Cytomegalovirus in Antiviral Protection by CD8 T Cells. Becker S, Fink A, Podlech J, Giese I, Schmiedeke JK, Bukur T, Reddehase MJ, Lemmermann NA. Front Cell Infect Microbiol; 2020 Jul 01; 10():454. PubMed ID: 32984075 [Abstract] [Full Text] [Related]
6. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. Kavanagh DG, Gold MC, Wagner M, Koszinowski UH, Hill AB. J Exp Med; 2001 Oct 01; 194(7):967-78. PubMed ID: 11581318 [Abstract] [Full Text] [Related]
9. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. Kleijnen MF, Huppa JB, Lucin P, Mukherjee S, Farrell H, Campbell AE, Koszinowski UH, Hill AB, Ploegh HL. EMBO J; 1997 Feb 17; 16(4):685-94. PubMed ID: 9049298 [Abstract] [Full Text] [Related]
10. Identification of a K(d)-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84. Holtappels R, Thomas D, Reddehase MJ. J Gen Virol; 2000 Dec 17; 81(Pt 12):3037-3042. PubMed ID: 11086134 [Abstract] [Full Text] [Related]
12. An endocytic YXXΦ (YRRF) cargo sorting motif in the cytoplasmic tail of murine cytomegalovirus AP2 'adapter adapter' protein m04/gp34 antagonizes virus evasion of natural killer cells. Fink A, Blaum F, Babic Cac M, Ebert S, Lemmermann NA, Reddehase MJ. Med Microbiol Immunol; 2015 Jun 17; 204(3):383-94. PubMed ID: 25850989 [Abstract] [Full Text] [Related]
13. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. Pinto AK, Jamieson AM, Raulet DH, Hill AB. J Virol; 2007 Nov 17; 81(22):12564-71. PubMed ID: 17855532 [Abstract] [Full Text] [Related]
14. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. Simon CO, Holtappels R, Tervo HM, Böhm V, Däubner T, Oehrlein-Karpi SA, Kühnapfel B, Renzaho A, Strand D, Podlech J, Reddehase MJ, Grzimek NK. J Virol; 2006 Nov 17; 80(21):10436-56. PubMed ID: 16928768 [Abstract] [Full Text] [Related]
15. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. Pahl-Seibert MF, Juelch M, Podlech J, Thomas D, Deegen P, Reddehase MJ, Holtappels R. J Virol; 2005 May 17; 79(9):5400-13. PubMed ID: 15827154 [Abstract] [Full Text] [Related]
16. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication. Morello CS, Ye M, Spector DH. J Virol; 2002 May 17; 76(10):4822-35. PubMed ID: 11967299 [Abstract] [Full Text] [Related]
17. Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. Babić M, Pyzik M, Zafirova B, Mitrović M, Butorac V, Lanier LL, Krmpotić A, Vidal SM, Jonjić S. J Exp Med; 2010 Nov 22; 207(12):2663-73. PubMed ID: 21078887 [Abstract] [Full Text] [Related]
19. Cytomegaloviral control of MHC class I function in the mouse. Hengel H, Reusch U, Gutermann A, Ziegler H, Jonjic S, Lucin P, Koszinowski UH. Immunol Rev; 1999 Apr 22; 168():167-76. PubMed ID: 10399073 [Abstract] [Full Text] [Related]
20. Altered-Self MHC Class I Sensing via Functionally Disparate Paired NK Cell Receptors Counters Murine Cytomegalovirus gp34-Mediated Immune Evasion. Cronk JM, Dziewulska KH, Puchalski P, Crittenden RB, Hammarskjöld ML, Brown MG. J Immunol; 2022 Oct 15; 209(8):1545-1554. PubMed ID: 36165178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]